Thoracoscopy Preparation and Management

Pre-Procedure Assessment and Preparation

The American Thoracic Society recommends respiratory function testing for patients with suspected COPD, including spirometry and arterial blood gas measurement if FEV1 <40% predicted and/or SaO2 <93% 2, 1
Cardiac risk stratification should avoid thoracoscopy within 6 weeks of myocardial infarction when possible 2
Asthmatic patients should be premedicated with bronchodilators 2, 1
Coagulation studies, including platelet count, prothrombin time, and partial thromboplastin time, should be checked before any biopsy procedure 3, 4, 1
Routine testing is only required for patients with known bleeding risk factors 2, 1
Oral anticoagulants should be stopped at least 3 days before thoracoscopy or reversed with low-dose vitamin K 4, 5, 1
If anticoagulation is continued, INR should be reduced to <2.5 and bridged with heparin 3, 5, 1
Prophylactic antibiotics should be administered to patients who are asplenic, have heart valve prostheses, or have previous endocarditis history 2, 1
Patients should be NPO for 4 hours and clear fluids permitted up to 2 hours before procedure 3, 4, 5
Intravenous access should be established before procedure commences and maintained until end of recovery period 3, 4, 5, 1

Pulse oximetry is mandatory for continuous monitoring 3, 5, 2, 1
Oxygen supplementation should maintain oxygen saturation ≥90% to reduce arrhythmia risk 3, 5, 2, 1
ECG monitoring should be considered for patients with severe cardiac disease or hypoxia despite oxygen supplementation 6, 3, 7, 1
Local anesthetic dosing should be limited to 8.2 mg/kg (approximately 29 ml of 2% solution for 70 kg patient) 6, 3, 5
Sedative administration should use incremental doses to achieve adequate sedation and amnesia 6, 3, 7

Oxygen supplementation may be required, particularly for patients with impaired lung function or who received sedation 6, 3, 7, 2, 1
A chest radiograph should be obtained at least 1 hour post-procedure to exclude pneumothorax 6, 3, 7, 2
Patients should be warned about delayed pneumothorax development and provided with verbal and written advice 6, 3, 7, 2
Post-sedation restrictions should advise patients not to drive, sign legal documents, or operate machinery for 24 hours 6, 3, 7, 2, 1
Discharge planning should ensure day-case patients are accompanied home and high-risk patients have overnight supervision 6, 3, 7, 2, 1

Decontamination should occur at the beginning and end of the list, and between patients 6, 3, 7
Initial cleaning with detergent is the most critical step 6, 3, 7
Dedicated facility and trained staff should perform cleaning 6, 3, 7
Standard immersion in 2% glutaraldehyde for 20 minutes is recommended for routine cases 6, 3, 7
Extended immersion for 60 minutes is recommended for atypical mycobacterial infections or HIV-positive patients with respiratory symptoms 6, 5, 7
Sterile water, such as autoclaved or filtered water (0.2 μm filters), should be used for rinsing 6, 7
Water pathway maintenance should include regular cleaning and disinfection of tanks, filters, and pipework 6, 7
Resistant organisms, such as Mycobacterium chelonae, should be treated with chlorine-releasing agent or peracetic acid 6, 7
Equipment tracking should record which thoracoscope and reusable equipment used on each patient, plus decontamination procedure details 6, 7

Inadequate coagulation assessment can lead to complications, even in short procedures requiring biopsy 1
Respiratory optimization failure, such as uncontrolled asthma or unassessed severe COPD, significantly increases complications 2, 1
Delayed pneumothorax recognition can be avoided with post-procedure chest radiograph 6, 3, 7, 2